Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pseudoephedrine hydrochloride (substance) |
Is a |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine measurement |
Component |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Pseudoephedrine adverse reaction |
Causative agent |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Allergy to pseudoephedrine (finding) |
Causative agent |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Urine pseudoephedrine measurement |
Component |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
pseudoephedrin 30 mg/5 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
azatadinmaleat 1 mg + pseudoephedrinsulfat 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 15 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/1 ml/4 mg/1 ml/25 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat 2 mg/1 ml + dextromethorphanhydrobromid 4 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + pseudoephedrinhydrochlorid 4 mg/5 ml/60 mg/5 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + pseudoephedrinhydrochlorid 2 mg/1 ml/25 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat 2 mg/5 ml + pseudoephedrinhydrochlorid 30 mg/5 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + pseudoephedrinhydrochlorid 8 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
fexofenadinhydrochlorid + pseudoephedrinhydrochlorid 60 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
loratadin + pseudoephedrinsulfat 5 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/5 ml 10 mg/5 ml 30 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
cetirizinhydrochlorid + pseudoephedrin 5 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
chlorpheniraminmaleat 8 mg + methscopolaminnitrat 2,5 mg + pseudoephedrinhydrochlorid 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Fexofenadine hydrochloride + pseudoephedrine hydrochloride 60mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 45 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 30 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml/12,5 mg/5 ml/60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 1 mg/1 ml/4 mg/1 ml/15 mg/1 ml dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + pseudoephedrinhydrochlorid 1 mg/1 ml/15 mg/1 ml dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Ibuprofen+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
pseudoephedrinforbindelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Pseudoephedrine sulfate |
Is a |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
paracetamol + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
pseudoephedrin 15 mg/5 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing naproxen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
naproxennatrium 220 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing chlorphenamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing dexbrompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing codeine and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Chlorphenamine- and hydrocodone- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Product containing dexbrompheniramine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing dextromethorphan and doxylamine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Product containing dextromethorphan and diphenhydramine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Product containing chlorphenamine and codeine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing dextromethorphan and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Pseudoephedrine + guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
brompheniraminmaleat + pseudoephedrin + paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing chlorphenamine and ibuprofen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
chlorpheniramin 2 mg + ibuprofen 200 mg + pseudoephedrin 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
pseudoephedrin 240 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
guaifenesin 1200 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
guaifenesin 600 mg med modificeret udløsning/pseudoephedrin 60 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing desloratadine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
desloratadin 5 mg + pseudoephedrin 240 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
dexbrompheniramin 6 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing chlorphenamine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing diphenhydramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
naproxen 200 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
desloratadin 2,5 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
ibuprofen 100 mg + pseudoephedrin 15 mg 5 ml oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
ibuprofen 200 mg + pseudoephedrin 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing brompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Product containing acrivastine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing pseudoephedrine and triprolidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Product containing ibuprofen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Product containing codeine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing chlorphenamine and dextromethorphan and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing chlorphenamine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Allergy to pseudoephedrine (finding) |
Causative agent |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
ibuprofen 200 mg + pseudoephedrin 30 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
ibuprofen 200 mg + pseudoephedrin 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
ibuprofen 200 mg + pseudoephedrin 30 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
1 |
Product containing carbinoxamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Product containing fexofenadine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
2 |
Pseudoephedrine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|
Guaifenesin 1200mg /pseudoephedrine 120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Some |
|